{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:12:47Z","timestamp":1790179967937,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cct.2022.106933","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T13:01:35Z","timestamp":1663851695000},"page":"106933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial"],"prefix":"10.1016","volume":"122","author":[{"given":"Michael J.","family":"Telch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Zaizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Papini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2022.106933_bb0005","doi-asserted-by":"crossref","first-page":"1353383","DOI":"10.1080\/20008198.2017.1353383","article-title":"Trauma and PTSD in the WHO world mental health surveys","volume":"8","author":"Kessler","year":"2017","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.cct.2022.106933_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/wps.20608","article-title":"Estimating the risk of PTSD in recent trauma survivors: results of the international consortium to predict PTSD (ICPP)","volume":"18","author":"Shalev","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.36811\/ijpmh.2019.110003","article-title":"The economic burden of PTSD. A brief review of salient literature","author":"McGowan","year":"2019","journal-title":"Int. J. Psychiatr. Ment. Health"},{"key":"10.1016\/j.cct.2022.106933_bb0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1359-1789(03)00045-4","article-title":"Psychological sequelae of combat violence: a review of the impact of PTSD on the veteran\u2019s family and possible interventions","volume":"9","author":"Galovski","year":"2004","journal-title":"Aggress. Violent Behav."},{"key":"10.1016\/j.cct.2022.106933_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2019.109744","article-title":"Physical health burden of PTSD, depression, and their comorbidity in the U.S. veteran population: morbidity, functioning, and disability","volume":"124","author":"Nichter","year":"2019","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.cct.2022.106933_bb0030","first-page":"4","article-title":"Posttraumatic stress disorder: the burden to the individual and to society","volume":"61","author":"Kessler","year":"2000","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.cct.2022.106933_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwp456","article-title":"Posttraumatic stress disorder and completed suicide","volume":"171","author":"Gradus","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cct.2022.106933_bb0040","series-title":"Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence","article-title":"Board on Population Health and Public Health Practice, Committee on Treatment of Posttraumatic Stress Disorder","author":"Institute of Medicine","year":"2008"},{"key":"10.1016\/j.cct.2022.106933_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1037\/a0031474","article-title":"Meta-analysis of dropout in treatments for posttraumatic stress disorder","volume":"81","author":"Imel","year":"2013","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.cct.2022.106933_bb0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jts.22038","article-title":"A systematic review of dropout from psychotherapy for posttraumatic stress disorder among Iraq and Afghanistan combat veterans","volume":"28","author":"Goetter","year":"2015","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.cct.2022.106933_bb0055","first-page":"1","article-title":"A review of human studies assessing Cannabidiol\u2019s (CBD) therapeutic actions and potential","author":"White","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified Cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs."},{"key":"10.1016\/j.cct.2022.106933_bb0065","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of Cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cct.2022.106933_bb0070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fphar.2016.00454","article-title":"Cannabidiol regulation of learned fear: implications for treating anxiety-related disorders","volume":"7","author":"Jurkus","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11920-019-1026-z","article-title":"Cannabinoid regulation of fear and anxiety: an update","volume":"21","author":"Papagianni","year":"2019","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.cct.2022.106933_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1037\/abn0000224","article-title":"Chronic cannabis use is associated with impaired fear extinction in humans","volume":"126","author":"Papini","year":"2017","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.cct.2022.106933_bb0085","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1101\/lm.1081908","article-title":"Chronic cannabinoid administration in vivo compromises extinction of fear memory","volume":"15","author":"Lin","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.cct.2022.106933_bb0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fnins.2018.00502","article-title":"Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: from bench research to confirmation in human trials","volume":"12","author":"Bitencourt","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cct.2022.106933_bb0095","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/npp.2013.317","article-title":"D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial","volume":"39","author":"Difede","year":"2014","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.cct.2022.106933_bb0100","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.4088\/JCP.16m10936","article-title":"Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial","volume":"78","author":"Zoellner","year":"2017","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.cct.2022.106933_bb0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1176\/appi.ajp.2017.17050481","article-title":"Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial","volume":"175","author":"Brunet","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of Cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.cct.2022.106933_bb0115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.cct.2022.106933_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of Cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0130","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1523\/JNEUROSCI.0153-06.2006","article-title":"Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes","volume":"26","author":"Kamprath","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cct.2022.106933_bb0135","article-title":"Use of cannabinoids for the treatment of patients with post-traumatic stress disorder","author":"Forsythe","year":"2021","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0140","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.cct.2022.106933_bb0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuropharm.2017.07.024","article-title":"Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors","volume":"125","author":"Stern","year":"2017","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.cct.2022.106933_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroscience.2017.07.018","article-title":"Effects of cannabinoid drugs on aversive or rewarding drug-associated memory extinction and reconsolidation","volume":"370","author":"Stern","year":"2018","journal-title":"Neuroscience."},{"key":"10.1016\/j.cct.2022.106933_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101339","article-title":"Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies","volume":"53","author":"Suraev","year":"2020","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.cct.2022.106933_bb0160","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J."},{"key":"10.1016\/j.cct.2022.106933_bb0165","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders: CBD regulation of fear and drug reward processing","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/17460441.2013.780021","article-title":"Latest advances in the discovery of fatty acid amide hydrolase inhibitors","volume":"8","author":"Bisogno","year":"2013","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.cct.2022.106933_bb0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cct.2022.106933_bb0180","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0185","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2013.04.045","article-title":"Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors","volume":"250","author":"Do Monte","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cct.2022.106933_bb0195","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1016\/S0924-977X(14)70511-5","article-title":"P.1.J.006 involvement of the prelimbic cortex in the disruptive effect of cannabidiol on fear memory reconsolidation","volume":"24","author":"Stern","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Braz. J. Psychiatr."},{"key":"10.1016\/j.cct.2022.106933_bb0205","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson\u2019s disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.cct.2022.106933_bb0215","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/16-005","article-title":"Effectiveness of Cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report","volume":"20","author":"Shannon","year":"2016","journal-title":"Perm J."},{"key":"10.1016\/j.cct.2022.106933_bb0220","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.pnpbp.2008.04.008","article-title":"The role of the CB1 receptor in the regulation of sleep","volume":"32","author":"Murillo-Rodr\u00edguez","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0225","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/2167702614553230","article-title":"Mental disorders as causal systems: a network approach to posttraumatic stress disorder","volume":"3","author":"McNally","year":"2015","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.cct.2022.106933_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnsys.2014.00046","article-title":"Sleep for cognitive enhancement","volume":"8","author":"Diekelmann","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.cct.2022.106933_bb0235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PRA.0000000000000091","article-title":"Benzodiazepines for PTSD: a systematic review and Meta-analysis","volume":"21","author":"Guina","year":"2015","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.cct.2022.106933_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.729800","article-title":"Antidepressant and anxiolytic effects of medicinal Cannabis use in an observational trial","volume":"12","author":"Martin","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0245","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/can.2019.0096","article-title":"A cross-sectional and prospective comparison of medicinal Cannabis users and controls on self-reported health","volume":"6","author":"Schlienz","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.cct.2022.106933_bb0250","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated Cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.cct.2022.106933_bb0255","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/acm.2018.0437","article-title":"Cannabidiol in the treatment of post-traumatic stress disorder: a case series","volume":"25","author":"Elms","year":"2019","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.cct.2022.106933_bb0260","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JCP.0000000000001405","article-title":"Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic","volume":"41","author":"Pacheco","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0265","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20603","article-title":"Efficacy and safety of Cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial","volume":"4","author":"Crippa","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cct.2022.106933_bb0270","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fpsyt.2021.620073","article-title":"Prospects for the use of cannabinoids in psychiatric disorders","volume":"12","author":"Graczyk","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0275","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","article-title":"The \u201centourage effect\u201d: terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders","volume":"18","author":"Ferber","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cct.2022.106933_bb0290","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnbeh.2019.00174","article-title":"Cannabidiol and the remainder of the plant extract modulate the effects of \u03949-tetrahydrocannabinol on fear memory reconsolidation","volume":"13","author":"Murkar","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.cct.2022.106933_bb0295","series-title":"Mini International Neuropsychiatric Interview. PsycTESTS Dataset","author":"Lecrubier","year":"2013"},{"key":"10.1016\/j.cct.2022.106933_bb0300","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-09964-4_4","article-title":"From uniform definitions to prediction of risk: the Columbia suicide severity rating scale approach to suicide risk assessment","author":"Posner","year":"2014","journal-title":"Suicide Phenomenol. Neurobiol."},{"key":"10.1016\/j.cct.2022.106933_bb0310","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1037\/pas0000260","article-title":"Psychometric analysis of the PTSD Checklist-5 (PCL-5) among treatment-seeking military service members","volume":"28","author":"Wortmann","year":"2016","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.cct.2022.106933_bb0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.cct.2022.106933_bb0320","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/1740774512465064","article-title":"Development of the Stanford expectations of treatment scale (SETS): a tool for measuring patient outcome expectancy in clinical trials","volume":"9","author":"Younger","year":"2012","journal-title":"Clin Trials."},{"key":"10.1016\/j.cct.2022.106933_bb0325","series-title":"Measuring Stress: A Guide for Health and Social Scientists","first-page":"1","article-title":"Perceived stress scale","volume":"10","author":"Cohen","year":"1994"},{"key":"10.1016\/j.cct.2022.106933_bb0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15402002.2012.636266","article-title":"Development of short forms from the PROMISTM sleep disturbance and sleep-related impairment item banks","volume":"10","author":"Yu","year":"2011","journal-title":"Behav. Sleep Med."},{"key":"10.1016\/j.cct.2022.106933_bb0335","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00213-019-05442-6","article-title":"Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis","volume":"237","author":"Appiah-Kusi","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cct.2022.106933_bb0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.anr.2012.08.004","article-title":"Review of the psychometric evidence of the perceived stress scale","volume":"6","author":"Lee","year":"2012","journal-title":"Asian Nurs. Res."},{"key":"10.1016\/j.cct.2022.106933_bb0345","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2022.106933_bb0350","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1007\/s11606-007-0333-y","article-title":"Screening for depression in medical settings with the patient health questionnaire (PHQ): a diagnostic meta-analysis","volume":"22","author":"Gilbody","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2022.106933_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2190\/T8EM-C8YH-373N-1UWD","article-title":"Assessing psychiatric impairment in primary care with the Sheehan disability scale","volume":"27","author":"Leon","year":"1997","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.cct.2022.106933_bb0360","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cct.2022.106933_bb0365","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group","volume":"28","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.cct.2022.106933_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2016.04.038","article-title":"Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting","volume":"164","author":"Gibbons","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2022.106933_bb0375","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1037\/0022-006X.76.2.272","article-title":"Validating the primary care posttraumatic stress disorder screen and the posttraumatic stress disorder checklist with soldiers returning from combat","volume":"76","author":"Bliese","year":"2008","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.cct.2022.106933_bb0380","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1542\/peds.2009-2712","article-title":"Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents","volume":"125","author":"Richardson","year":"2010","journal-title":"Pediatrics."},{"key":"10.1016\/j.cct.2022.106933_bb0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/da.20176","article-title":"A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults","volume":"24","author":"Marshall","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.cct.2022.106933_bb0390","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cct.2022.106933_bb0395","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cpr.2010.04.007","article-title":"A meta-analytic review of prolonged exposure for posttraumatic stress disorder","volume":"30","author":"Powers","year":"2010","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.cct.2022.106933_bb0400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2018","journal-title":"Braz. J. Psychiatr."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422002592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422002592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:57:30Z","timestamp":1761555450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714422002592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":80,"alternative-id":["S1551714422002592"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2022.106933","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2022.106933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106933"}}